Transient hyperpigmentation after calcipotriol ointment and PUVA therapy in psoriatic patients.
Vázqvez-López
F
F
Pérez-Oliva
N
N
D000328:Adult; D002117:Calcitriol / Q000008:administration & dosage* / Q000009:adverse effects*; D006801:Humans; D017495:Hyperpigmentation / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D009824:Ointments; D011701:PUVA Therapy / Q000009:adverse effects*; D011565:Psoriasis / Q000188:drug therapy*
D009824:Ointments; D002117:Calcitriol